Effect of Different Surgical Approaches of Granulomatous Mastitis
A Prospective Real-world Study of the Effect of Different Surgical Approaches on the Recurrence Rate and Aesthetic Outcome of Granulomatous Mastitis
1 other identifier
interventional
240
1 country
1
Brief Summary
The objective of this study was to prospectively investigate the effects of different surgical approaches on the recurrence rate and aesthetic outcome of patients with granulomatous mastitis. The patients were divided into traditional surgery group and plastic surgery group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 26, 2024
CompletedFirst Posted
Study publicly available on registry
December 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
December 2, 2024
November 1, 2024
3.2 years
November 26, 2024
November 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Recurrence rate
The recurrence rate of mastitis patients was compared between traditional surgery group and plastic surgery group.
2, 3, 5 year
Secondary Outcomes (1)
Aesthetics scores
2, 3, 5 year
Study Arms (2)
Breast-conserving plastic surgery group
EXPERIMENTALBreast-conserving plastic surgery
Traditional breast surgery group
ACTIVE COMPARATORTraditional breast surgery
Interventions
The commonly used breast conserving plastic surgery includes tennis racket, bat wing, V/J breast plasty, Grisotti and so on.
Eligibility Criteria
You may qualify if:
- Only the subjects who meet all the following criteria may be included in this study:
- Ability to understand the study procedures and contents, and willingness to voluntarily sign the written informed consent form;
- ≤Age≤75 years old, female;
- Histologically confirmed granulomatous mastitis;
- low and moderate risk for anesthesia.
You may not qualify if:
- The subjects who meet any of the following criteria shall not be included in this study:
- Absolute and relative contraindication for surgery;
- Previous history of breast cancer or other malignancies;
- Pregnancy;
- Any serious complications which caused patients not suitable to participate this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hubei Cancer Hospital
Wuhan, Hubei, 430060, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Xinhong Wu, Doctor
Hubei Cancer Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
November 26, 2024
First Posted
December 2, 2024
Study Start
November 1, 2024
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2027
Last Updated
December 2, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
Patient information was protected according to the privacy requirements of our unit.